Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsIV (INFUSION)Generic

ZOLEDRONIC ACID

ZOLEDRONIC ACID

Standard Dose
EQ 4MG BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: None (Tentative Approval)
Summary

Approval overview ZOLEDRONIC ACID is listed in Drugs@FDA under application 078580 (ANDA).

Marketing status: None (Tentative Approval) Active ingredient ZOLEDRONIC ACID Form and strength INJECTABLE; IV (INFUSION) - EQ 4MG BASE/VIAL Sponsor TEVA PARENTERAL Submission history Latest submission status date: 2009-06-09 00:00:00.

Structured Monograph

Clinical summary

Approval overview ZOLEDRONIC ACID is listed in Drugs@FDA under application 078580 (ANDA). Marketing status: None (Tentative Approval) Active ingredient ZOLEDRONIC ACID Form and strength INJECTABLE; IV (INFUSION) - EQ 4MG BASE/VIAL Sponsor TEVA PARENTERAL Submission history Latest submission status date: 2009-06-09 00:00:00. Submission type: ORIG.

Monitoring

  • • Review priority: UNKNOWN
  • • Marketing status: None (Tentative Approval)

Interaction Notes

  • No interaction notes stored yet.